Hartwig5 and Buchwald7 have reported catalyst systems that
support use of ammonia in the Pd-catalyzed conversion of aryl
halides to anilines. We also recently reported mild conditions
for the Pd-catalyzed conversion of aryl bromides to anilines
using benzophenone imine as the ammonia equivalent.2 The use
of benzophenone imine, however, generates an intermediate
ketimine that does not provide a convenient protecting group
for the aniline.
Room-Temperature Pd-Catalyzed Amidation of
Aryl Bromides Using tert-Butyl Carbamate
Swapna Bhagwanth,† Alex G. Waterson,
George M. Adjabeng, and Keith R. Hornberger*,§
Department of Medicinal Chemistry, Cancer Research,
Oncology R&D, GlaxoSmithKline, Research Triangle Park,
North Carolina 27709
During the course of our medicinal chemistry efforts around
an oncology target, it became desirable to perform a Pd-
catalyzed amination or amidation of an aryl bromide that directly
delivered an ammonia equivalent in a conveniently protected
form. Nearly all of the published ammonia equivalents cannot
fulfill this criterion, with one notable exception. The tert-
butyloxycarbonyl (Boc) group is a convenient and robust amine
protecting group, and there are a few examples of tert-butyl
carbamate being used as the ammonia equivalent in Cu-8 and
Pd-catalyzed9-13 amidations. In 1999, while reporting room-
temperature amination of aryl bromides using tri-tert-butylphos-
phine as ligand, Hartwig also first reported a few examples of
Pd-catalyzed amidation of aryl bromides using tert-butyl car-
bamate.9 These reactions were conducted at 100 °C and
employed sodium phenoxide as the base. Xantphos10,12,13 or
tri-tert-butylphosphine9,11 are frequently encountered as ligands
to effect this conversion, generally at elevated temperatures. Two
exceptions are a single conversion of an activated aryl bromide
at 45 °C12 and a few examples using a different carbamate (Cbz-
NH2) at 45 °C.10 As we were concomitantly pursuing milder
conditions for Pd-catalyzed aminations with benzophenone
imine, we wondered if similar conditions might be employed
to deliver a milder Pd-catalyzed amidation of aryl bromides
using tert-butyl carbamate. We now report the first reaction
conditions for amidations of aryl bromides with tert-butyl
carbamate at room temperature.
ReceiVed February 27, 2009
The scope of Pd-catalyzed synthesis of N-Boc-protected
anilines from aryl bromides and commercially available tert-
butyl carbamate is described. For the first time, this process
can be conducted at room temperature (17-22 °C) using a
combination of Pd2dba3 · CHCl3 and a monodentate ligand,
tert-butyl X-Phos. Use of sodium tert-butoxide is crucial to
the success of the reaction, which proceeds in 43-83% yield.
Pd-catalyzed conversion of aryl halides and their equivalents
to primary anilines traditionally incorporates an ammonia
equivalent.1 Benzophenone imine,1,2 (di)allyl amine,3 lithium
bis(trimethylsilyl)amide,4 and lithium amide5 have all been
successfully exploited to affect this conversion. Although general
scope has been established with these ammonia equivalents, the
reaction conditions remain relatively harsh because of high
temperatures and/or the use of strong bases. An exception is
the use of zinc bis(hexamethyldisilazide),6 which can be used
to convert actiVated aryl bromides to anilines at room temper-
ature. In this case, however, an air-sensitive ligand, tri-tert-butyl
phosphine, is required for the transformation. Recently, both
The reaction optimization using tert-butyl carbamate was
conducted concurrent to our benzophenone imine work. The
ligands surveyed (1-5) are shown in Figure 1, and Table 1
summarizes this study using conditions similar to our benzophe-
none imine ligand screen. 4-tert-Butylbromobenzene (6) with
tert-butyl carbamate (7) was used as the model substrate and
Pd2dba3 ·CHCl3 as the source of Pd(0). Conversion to the Boc-
(7) Surry, D. S.; Buchwald, S. L. J. Am. Chem. Soc. 2007, 129, 10354.
(8) (a) Minatti, A.; Buchwald, S. L. Org. Lett. 2008, 10, 2721. (b) McBriar,
M. D.; Guzik, H.; Shapiro, S.; Paruchova, J.; Xu, R.; Palani, A.; Clader, J. W.;
Cox, K.; Greenlee, W. J.; Hawes, B. E.; Kowalski, T. J.; O’Neill, K.; Spar,
B. D.; Weig, B.; Weston, D. J.; Farley, C.; Cook, J. J. Med. Chem. 2006, 49,
2294. (c) Hof, F.; Schar, M.; Scofield, D. M.; Fischer, F.; Diederich, F. HelV.
Chim. Acta 2005, 88, 2333. (d) Klapars, A.; Huang, X.; Buchwald, S. L. J. Am.
Chem. Soc. 2002, 124, 7421.
† GlaxoSmithKline Summer Talent Identification Program intern from the
Department of Medicinal Chemistry, University of Minnesota, 308 Harvard St
SE, Minneapolis, MN 55455.
(9) Hartwig, J. F.; Kawatsura, M.; Hauck, S. I.; Shaughnessy, K. H.; Alcazar-
Roman, L. M. J. Org. Chem. 1999, 64, 5575.
§ Present Address: OSI Pharmaceuticals, Inc., 1 Bioscience Park Drive,
Farmingdale, NY 11735.
(10) (a) Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101. (b) Kuwahara,
A.; Nakano, K.; Nozaki, K. J. Org. Chem. 2005, 70, 413. (c) Willis, M. C.;
Brace, G. N.; Holmes, I. P. Angew. Chem., Int. Ed. 2005, 44, 403. (d) Wannberg,
J.; Dallinger, D.; Kappe, C. O.; Larhed, M. J. Comb. Chem. 2005, 7, 574. (e)
Shi, F.; Smith, M. R., III; Maleczka, R. E. Org. Lett. 2006, 8, 1411.
(11) Dallas, A. S.; Gothelf, K. V. J. Org. Chem. 2005, 70, 3321.
(12) Terazono, Y.; Lidell, P. A.; Garg, V.; Kodis, G.; Brune, A.; Hambourger,
M.; Moore, A. L.; Moore, T. A.; Gust, D. J. Porphyrins Phthalocyanines 2005,
9, 706.
(1) Wolfe, J. P.; Åhman, J.; Sadighi, J. P.; Singer, R. A.; Buchwald, S. L.
Tetrahedron Lett. 1997, 38, 6367.
(2) Bhagwanth, S.; Adjabeng, G. M.; Hornberger, K. R. Tetrahedron. Lett.
2009, 50, 1582–1585.
(3) Jaime Figueroa, S.; Liu, Y.; Muchowski, J. M.; Putman, D. G. Tetrahe-
dron Lett. 1998, 39, 1313.
(4) (a) Lee, S.; Jorgensen, M.; Hartwig, J. F. Org. Lett. 2001, 3, 2729. (b)
Huang, X.; Buchwald, S. L. Org. Lett. 2001, 3, 3417.
(5) Shen, Q.; Hartwig, J. F. J. Am. Chem. Soc. 2006, 128, 10028.
(6) Lee, D-.Y.; Hartwig, J. F. Org. Lett. 2005, 7, 1169.
(13) Trabanco, A. A.; Vega, J. A.; Alejandro Fernandez, M. J. Org. Chem.
2007, 72, 8146.
4634 J. Org. Chem. 2009, 74, 4634–4637
10.1021/jo9004537 CCC: $40.75 2009 American Chemical Society
Published on Web 05/18/2009